MDGL

NASDAQ · Biotechnology

Madrigal Pharmaceuticals Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$515.25

-3.58 (-0.69%)

As of Sep 23, 7:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 22 92%

Hold 2 8%

Sell 0 0%

Price Target

Analyst Price Target -76.7% upside

Low Target $78.20

Average Target $119.83

High Target $127.79

Current Price $515.25

Current
$515.25

Target
$119.83

$78.20 $119.83 avg $127.79

Scenario Analysis

Bear Case

$78.20

-84.8%

Low target

Base Case

$119.83

-76.7%

Avg target

Bull Case

$127.79

+-75.2%

High target

Risk/Reward

0.9x

Unfavorable

Price in Context

52-Week High

$615.00

-16.2% from high

52-Week Low

$393.61

+30.9% from low

50-Day SMA

$526.21

-2.1% vs SMA

200-Day SMA

$421.32

+22.3% vs SMA

RSI (14)

32.6

Neutral

Target vs 52W High

$119.83

-80.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.8%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.3%